Menu Search
Equities

Veeva Systems Inc

VEEX:GER

Veeva Systems Inc

Actions
  • Price (EUR)187.60
  • Today's Change-5.95 / -3.07%
  • Shares traded0.00
  • 1 Year change+15.52%
  • Beta--
Data delayed at least 15 minutes, as of Apr 17 2024 16:35 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Veeva Systems Inc. is a provider of cloud solutions for the global life sciences industry. The Company offers span cloud software, data, and business consulting and is designed to meet the needs of its customers and their strategic business functions from research and development (R&D) through commercialization. The Company’s three product categories: Veeva Development Cloud, Veeva Commercial Cloud, and Veeva Data Cloud. Veeva Development Cloud includes application suites for the clinical, regulatory, and safety functions of life sciences companies, all built on its Veeva Vault platform. Veeva Vault Clinical advances clinical trial execution by providing a complete and connected technology ecosystem. Veeva Commercial Cloud is a product category comprised of software and analytics solutions. Its software offerings include Veeva CRM, Veeva Vault PromoMats, Veeva Vault Medical, and Veeva Crossix. Its data offerings include Veeva OpenData, Veeva Link, and Veeva Compass.

  • Revenue in USD (TTM)2.36bn
  • Net income in USD525.71m
  • Incorporated2007
  • Employees7.17k
  • Location
    Veeva Systems Inc4280 Hacienda DrivePLEASANTON 94588United StatesUSA
  • Phone+1 (925) 452-6500
  • Fax+1 (925) 452-6504
  • Websitehttps://www.veeva.com/medtech/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.